FrancophonIA/ELRC3.0 huggingface dataset:
English: Studies have not been performed in patients with liver or renal disease.
Slovenian: Tudi študij pri bolnikih z jetrno ali ledvično boleznijo ni bilo.
English: In clinical studies, delayed hypersensitivity reactions have been reported.
Slovenian: V kliničnih preskušanjih so poročali o poznih preobčutljivostnih reakcijah.
English: Chemical and physical in use stability of the diluted solution has been demonstrated for up to 28 days at 2 °C to 8 °C and for an additional 24 hours at 25 °C after removal from refrigeration.
Slovenian: Dokazano je bilo, da je razredčena raztopina zdravila Remicade kemično in fizikalno stabilna do 28 dni pri temperaturi 2 °C do 8 °C ter dodatnih 24 ur pri temperaturi 25 °C, po tem ko se vzame iz hladilnika.
English: Type 1 glass vial with rubber stopper and aluminium crimp protected by a plastic cap.
Slovenian: Viala (steklo tipa 1) z gumijastim zamaškom in aluminijasto zaporko, zaščiteno s plastično ploščico.
English: Calculate the total volume of reconstituted Remicade solution required.
Slovenian: Izračunajte celoten volumen potrebne rekonstituirane raztopine zdravila Remicade.
English: Elevations of ALT ≥ 5 x Upper Limit of Normal (ULN) have been observed (see Table 2).
Slovenian: Opazili so zvišanje vrednosti ALT na ≥ 5-kratnik zgornje meje normalnih vrednosti (glejte preglednico 2).
English: At baseline 53% of patients were receiving immunomodulator therapy (6-MP, AZA and/or MTX) and 62% of patients were receiving corticosteroids.
Slovenian: Na začetku študije je 53 % bolnikov prejemalo imunomodulatorje (6-MP, AZA in/ali MTX), 62 % bolnikov pa je prejemalo kortikosteroide.
English: Psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), psoriasis, ulcerative colitis and Crohn's disease
Slovenian: Psoriatični artritis, ankilozirajoči spondilitis (Bechterew sindrom), psoriaza, ulcerozni kolitis in Crohnova bolezen
English: Remicade is produced in packs of 1, 2, 3, 4 or 5 vials.
Slovenian: Zdravilo Remicade je pakirano po 1, 2, 3, 4 ali 5 vial.
English: Corticosteroid taper was permitted after week 8.
Slovenian: Zmanjševanje odmerka kortikosteroidov je bilo dovoljeno po 8. tednu.
English: • Fast heart beat (tachycardia) or palpitations
Slovenian: • hitro bitje srca (tahikardija) ali razbijanje (palpitacije)
English: Particular attention regarding the risk for infection should be paid when treating the elderly (see section 4.8).
Slovenian: Pri zdravljenju starejših je torej treba posvetiti posebno pozornost tveganju za nastanek okužbe (glejte poglavje 4.8).
English: Corticosteroids do not appear to affect the pharmacokinetics of infliximab to a clinically relevant extent.
Slovenian: Ni videti, da bi imeli kortikosteroidi klinično pomemben vpliv na farmakokinetiko infliksimaba.
English: Patients were followed up to 26 weeks.
Slovenian: Spremljali so jih do 26 tednov.
English: Table 10 Summary of PASI response, PGA response and percent of patients with all nails cleared at weeks 10, 24 and 50.
Slovenian: Preglednica 10 Povzetek odzivov PASI,vrednosti PGA in delež bolnikov z nohti brez psoriatičnih sprememb v 10, 24 in 50 tednu.
English: At week 2, all patients were assessed for clinical response and randomised to one of 3 treatment groups; a placebo maintenance group, 5 mg/kg maintenance group and 10 mg/kg maintenance group.
Slovenian: V drugem tednu zdravljenja so pri vseh bolnikih ocenili klinični odziv in jih naključno razvrstili v eno od 3 terapevtskih skupin: skupino za vzdrževalno zdravljenje s placebom, skupino za vzdrževalno zdravljenje z odmerkom 5 mg/kg in skupino za vzdrževalno zdravljenje z odmerkom 10 mg/kg.
English: The educational programme consists of a patient reminder card to be held by the patient.
Slovenian: Izobraževalni program obsega opozorilno kartico za bolnika, ki jo ima bolnik pri sebi.
English: Concurrent use of stable doses of conventional therapies was permitted, and 92% of patients continued to receive these therapies.
Slovenian: Sočasno jemanje stalnih odmerkov konvencionalnih zdravil je bilo dovoljeno in 92 % bolnikov je med študijo še naprej prejemalo to terapijo.
English: Patients who were randomised to the placebo maintenance group and then later crossed over to infliximab are included in the infliximab group in the ALT analysis.
Slovenian: Bolniki, ki so jih naključno razporedili v skupino za vzdrževalno zdravljenje s placebom in so potem prešli v skupino za zdravljenje z infliksimabom, so bili pri analizi ALT vključeni v infliksimabovo skupino.
English: Appropriate empiric antifungal therapy should be considered while a diagnostic workup is being performed taking into account both the risk for severe fungal infection and the risks of antifungal therapy.
Slovenian: Med izvajanjem diagnostičnih preiskav je treba razmisliti o ustreznem empiričnem protiglivičnem zdravljenju, upoštevajoč tako tveganje za hudo glivično okužbo kot tudi tveganja samega protiglivičnega zdravljenja.
English: There are no known side effects of having too much of Remicade.
Slovenian: Ni poznanih neželenih učinkov zaradi prejetja prevelikega odmerka zdravila Remicade.
English: • Inflamed liver caused by a problem with the immune system (autoimmune hepatitis)
Slovenian: • vneta jetra zaradi težav z imunskim sistemom (avtoimunski hepatitis)
English: The reduction in incidence of colectomy was also examined in another randomised, double-blind study (C0168Y06) in hospitalised patients (n = 45) with moderately to severely active ulcerative colitis who failed to respond to intravenous corticosteroids and who were therefore at higher risk for colectomy.
Slovenian: Zmanjšanje incidence kolektomij so proučevali še v eni randomizirani, dvojno slepi študiji (C0168Y06) pri hospitaliziranih bolnikih (n = 45) z zmerno do močno aktivnim ulceroznim kolitisom, ki se niso odzvali na zdravljenje z intravenskimi kortikosteroidi in so imeli zato večje tveganje, da bo pri njih potrebna kolektomija.
English: Immunogenicity Antibodies to infliximab were detected in 4 (7.7%) patients through week 54.
Slovenian: Imunogenost Protitelesa proti infliksimabu so v obdobju do konca 54. tedna ugotovili pri 4 (7,7 %) bolnikih.
English: 19 weeks
Slovenian: 19 tednov
English: Appropriate screening tests (e.g. tuberculin skin test, chest X-ray, and/or Interferon Gamma Release Assay), should be performed in all patients (local recommendations may apply).
Slovenian: Pri vseh bolnikih je treba opraviti ustrezne presejalne teste (npr. tuberkulinski kožni test, rentgensko slikanje prsnega koša in/ali test sproščanja interferona gama) (v skladu z lokalnimi priporočili).
English: Patients should be advised to seek immediate medical advice if they experience any delayed adverse reaction (see section 4.8).
Slovenian: Bolnikom naročite, naj nemudoma poiščejo zdravniško pomoč, če opazijo katerega od poznih neželenih učinkov (glejte poglavje 4.8).
English: Administer the infusion solution over a period of not less than the infusion time recommended (see section 4.2).
Slovenian: Infuzijsko raztopino infundirajte bolniku v času, ki naj ne bo krajši od priporočenega trajanja infuzije (glejte poglavje 4.2).
English: In both studies, physical function and quality of life as measured by the BASFI and the physical component score of the SF-36 were also improved significantly.
Slovenian: V obeh študijah sta se bistveno izboljšala telesno stanje bolnikov in kakovost njihovega življenja merjeno po lestvici BASFI, pa tudi telesna komponenta ocene po SF-36 je bila bistveno izboljšana.
English: All patients with ulcerative colitis who are at increased risk for dysplasia or colon carcinoma (for example, patients with long-standing ulcerative colitis or primary sclerosing cholangitis), or who had a prior history of dysplasia or colon carcinoma should be screened for dysplasia at regular intervals before therapy and throughout their disease course.
Slovenian: Pri vseh bolnikih z ulceroznim kolitisom, pri katerih obstaja povečano tveganje za displazijo ali karcinom kolona (na primer pri bolnikih z dolgotrajnim ulceroznim kolitisom ali primarnim sklerozantnim holangitisom) ter pri tistih, ki imajo displazijo ali karcinom kolona v pretekli anamnezi, morate redno opravljati presejalne teste za displazijo, tako pred zdravljenjem kot med samo boleznijo.
English: • In case you have received Remicade while you were pregnant, it is important that you inform your baby's doctor about it before your baby receives any vaccine.
Slovenian: • Če ste med nosečnostjo prejeli zdravilo Remicade, je pomembno, da o tem obvestite zdravnika vašega dojenčka, preden dojenček prejme katero koli cepivo.
English: Almost all patients had received treatment with AZA or 6-MP concomitantly with or immediately prior to a TNF-blocker.
Slovenian: Skoraj vsi bolniki so bili zdravljeni z AZA ali 6-MP, bodisi sočasno z zaviralcem TNF ali neposredno pred uporabo zaviralca TNF.
English: • It is very important that you tell your doctor if you have ever had TB, or if you have been in close contact with someone who has had TB.
Slovenian: • Zelo pomembno je, da zdravniku poveste, če ste kdaj imeli tuberkulozo ali če ste bili v tesnem stiku s tuberkuloznim bolnikom.
English: Efficacy and safety were assessed in two multicenter, double-blind, placebo-controlled studies in patients with active psoriatic arthritis.
Slovenian: Učinkovitost in varnost zdravila so ocenjevali v dveh multicentričnih, dvojno slepih in s placebom kontroliranih študijah pri bolnikih z aktivnim psoriatičnim artritisom.
English: • Do not use this medicine if it is discoloured or if there are particles present.
Slovenian: • Ne uporabljajte tega zdravila, če opazite, da je raztopina spremenila barvo ali če vsebuje delce.
English: Concomitant stable doses of oral aminosalicylates, corticosteroids, and/or immunomodulatory agents were permitted.
Slovenian: Dovoljeni so bili sočasni stalni odmerki peroralnih aminosalicilatov, kortikosteroidov in/ali imunomodulatorjev.
English: • Convulsions, nerve problems
Slovenian: • epileptični krči, težave z živčevjem
English: Median follow-up is based on patients treated.
Slovenian: Mediana dolžine spremljanja bolnikov je bila določena samo z upoštevanjem zdravljenih bolnikov.
English: If jaundice and/or ALT elevations ≥ 5 times the upper limit of normal develop(s), Remicade should be discontinued, and a thorough investigation of the abnormality should be undertaken.
Slovenian: Če se pojavi zlatenica in/ali zvišanje vrednosti ALT ≥ 5-kratno zgornjo mejo normale, prenehajte z uporabo zdravila Remicade in temeljito raziščite vzroke za nenormalne izvide.
English: Remicade infliximab
Slovenian: Remicade infliksimab
English: While the numbers of patients in each subgroup are too small to make any definitive conclusions about the effect of age on safety events, there were higher proportions of patients with serious adverse events and discontinuation due to adverse events in the younger age group than in the older age group.
Slovenian: Število bolnikov v vsaki podskupini je sicer premajhno, da bi dopuščalo dokončne sklepe o vplivu starosti na varnost zdravljenja, vendar pa sta bila deleža bolnikov z resnimi neželenimi učinki in s prekinitvijo zdravljenja zaradi neželenih učinkov v mlajši starostni skupini večja kot v starejši.
English: Corticosteroid tapering was permitted after week 6.
Slovenian: Zmanjševanje odmerka kortikosteroida je bilo dovoljeno po 6. tednu.
English: • Possible signs of cancer including but not limited to swelling of lymph nodes, weight loss, fever, unusual skin nodules, changes in moles or skin colouring, or unusual vaginal bleeding.
Slovenian: • možni znaki raka, vključno z, vendar ne omejeno na otekanje bezgavk, izgubo telesne mase, zvišano telesno temperaturo, nenavadnimi kožnimi vozliči, spremembami znamenj ali barve kože, ali nenavadne vaginalne krvavitve.
English: If you forget or miss an appointment to receive Remicade, make another appointment as soon as possible.
Slovenian: Če ste pozabili ali izpustili odmerek zdravila Remicade Če ste pozabili ali izpustili dogovorjen termin, da bi prejeli zdravilo Remicade, se čim prej dogovorite za naslednjega.
English: In the 3 mg/kg Remicade group, 4 out of 60 patients had a serious infusion reaction and 3 patients reported a possible anaphylactic reaction (2 of which were among the serious infusion reactions).
Slovenian: V skupini, ki je zdravilo Remicade prejemala v odmerku 3 mg/kg, so imeli 4 od 60-tih bolnikov resno z infuzijo povezano reakcijo, pri 3 pa so poročali o možni anafilaktični reakciji (od tega sta 2 sodili med resne z infuzijo povezane reakcije).
English: In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X-ray, has been demonstrated (see section 5.1).
Slovenian: V teh populacijah bolnikov so pokazali zmanjšanje hitrosti napredovanja okvare sklepov, ki so jo ugotavljali z rentgenskim slikanjem (glejte poglavje 5.1).
English: Therefore, the combination of Remicade and anakinra is not recommended.
Slovenian: Kombiniranje zdravila Remicade in anakinre torej ni priporočljivo.
English: • Patients with COPD and patients who are heavy smokers may have a higher risk of developing cancer with Remicade treatment.
Slovenian: • Bolniki s KOPB in tisti, ki veliko kadijo, imajo lahko povečano tveganje za nastanek raka pri zdravljenju z zdravilom Remicade.
English: At week 24, all placebo-treated patients crossed over to infliximab induction.
Slovenian: V 24. tednu so vsi s placebom zdravljeni bolniki prešli na uvajanje infliksimaba.
English: If these medicines do not work well enough, you will be given Remicade which you will take in combination with another medicine called methotrexate to:
Slovenian: Če ta zdravila ne delujejo dovolj dobro, boste prejeli zdravilo Remicade skupaj z zdravilom, imenovanim metotreksat, za:
English: During Remicade treatment, other concomitant therapies, e.g., corticosteroids and immunosuppressants should be optimised.
Slovenian: Med zdravljenjem z zdravilom Remicade je treba optimizirati druge sočasne terapije, npr. s kortikosteroidi in zdravili za zaviranje imunske odzivnosti.
English: • A type of blood cancer (lymphoma)
Slovenian: • vrsta krvnega raka (limfom)
English: Due to its inhibition of TNF, infliximab administered during pregnancy could affect normal immune responses in the newborn.
Slovenian: Ker infliksimab zavira TNF, lahko pri uporabi v času nosečnosti vpliva na normalni imunski odziv novorojenčka.
English: Powder for concentrate for solution for infusion 1 vial 100 mg
Slovenian: prašek za koncentrat za raztopino za infundiranje 1 viala 100 mg
English: If a patient has an inadequate response or loses response after this period, consideration may be given to increase the dose step-wise by approximately 1.5 mg/kg, up to a maximum of 7.5 mg/kg every 8 weeks.
Slovenian: Če se bolnik nezadostno odzove na zdravilo ali če pri njem odziv pozneje izgine, mu lahko tudi postopoma povečujete odmerek za približno 1,5 mg/kg na vsakih 8 tednov, do največ 7,5 mg/kg.
English: Use of TNF-blocking agents, including infliximab, has been associated with cases of new onset or exacerbation of clinical symptoms and/or radiographic evidence of central nervous system demyelinating disorders, including multiple sclerosis, and peripheral demyelinating disorders, including Guillain-Barré syndrome.
Slovenian: Uporaba zaviralcev TNF vključno z infliksimabom je bila povezana s primeri novega pojava oz. poslabšanja kliničnih simptomov in/ali z rentgenskimi znaki demielinizirajoče bolezni osrednjega živčevja, vključno z multiplo sklerozo, in demielinizirajoče bolezni perifernega živčevja, vključno z Guillain-Barréjevim sindromom.
English: In REACH, 17.5% of randomised patients experienced 1 or more infusion reactions.
Slovenian: V preskušanju REACH se je pri 17,5 % naključno razvrščenih bolnikov pojavila ena oziroma več z infuzijo povezanih reakcij.
English: Population pharmacokinetic analysis based on data obtained from patients with ulcerative colitis (N = 60), Crohn's disease (N = 112), juvenile rheumatoid arthritis (N = 117) and Kawasaki disease (N = 16) with an overall age range from 2 months to 17 years indicated that exposure to infliximab was dependent on body weight in a non-linear way.
Slovenian: Analiza populacijske farmakokinetike na podlagi podatkov, pridobljenih pri bolnikih z ulceroznim kolitisom (n = 60), Crohnovo boleznijo (N = 112), juvenilnim revmatoidnim artritisom (N = 117) in boleznijo Kawasaki (N = 16) v starostni skupini od 2 mesecev do 17 let, je pokazala, da je izpostavljenost infliksimabu nelinearno odvisna od telesne mase.
English: Cases of TB have been reported in patients treated with Remicade, even in patients who have already been treated with medicines for TB.
Slovenian: Pri bolnikih, zdravljenih z zdravilom Remicade, so poročali o primerih tuberkuloze, tudi pri bolnikih, ki so že bili zdravljeni z zdravili proti TBC.
English: In responding patients, the alternative strategies for continued treatment are:
Slovenian: Pri bolnikih, ki so se odzvali na zdravilo, so druge možnosti nadaljnjega zdravljenja naslednje:
English: Placebo patients received methotrexate while infliximab patients received both infliximab and methotrexate.
Slovenian: Bolniki iz placebo skupine so prejemali metotreksat, medtem ko so bolniki iz infliksimabove skupine prejemali tako infliksimab kot metotreksat.
English: At 38 weeks, 9 of 101 patients treated with Remicade (2 at 5 mg/kg and 7 at 10 mg/kg) died compared to one death among the 49 patients on placebo.
Slovenian: Po 38 tednih je umrlo 9 od 101 bolnikov, zdravljenih z zdravilom Remicade (2 z odmerkom 5 mg/kg in 7 z odmerkom 10 mg/kg), v primerjavi z eno smrtjo pri 49 bolnikih, ki so prejemali placebo.
English: AZA was given at a dose of 2.5 mg/kg daily.
Slovenian: AZA so bolniki prejemali v odmerku 2,5 mg/kg na dan.
English: 14 weeks
Slovenian: 14 tednov
English: • Infection of the skin due to a fungus
Slovenian: • okužba kože zaradi glivic
English: In the 6 mg/kg group, 2 out of 57 patients had a serious infusion reaction, one of whom had a possible anaphylactic reaction (see section 4.4).
Slovenian: V skupini, ki je zdravilo prejemala v odmerku 6 mg/kg, pa sta imela 2 od 57-tih bolnikov resno z infuzijo povezano reakcijo in eden od njiju je morda imel anafilaktično reakcijo (glejte poglavje 4.4).
English: • This medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 °C for a single period of up to six months, but not beyond the original expiry date.
Slovenian: • To zdravilo se lahko shranjuje tudi v originalni škatli izven hladilnika do največ 25 °C za enkratno obdobje do 6 mesecev, vendar ne dlje od originalnega datuma izteka roka uporabnosti.
English: • Some patients treated with infliximab have developed certain kinds of skin cancer.
Slovenian: • Pri nekaterih bolnikih, zdravljenih z infliksimabom, so se pojavile določene vrste kožnega raka.
English: Analysis was based on subjects with nail psoriasis at baseline (81.8% of subjects).
Slovenian: Analiza se nanaša na preiskovance, ki so imeli psoriazo nohtov na začetku študije (81,8 % preiskovancev).
English: • Immune disorders that could affect the lungs, skin and lymph nodes (such as sarcoidosis).
Slovenian: • imunske bolezni, ki lahko prizadenejo pljuča, kožo in bezgavke (na primer sarkoidoza)
English: In clinical studies, mild or moderate elevations of ALT and AST have been observed in patients receiving Remicade without progression to severe hepatic injury.
Slovenian: V kliničnih preskušanjih so opažali blago ali zmerno zvišanje vrednosti ALT in AST pri bolnikih, ki so prejemali zdravilo Remicade, brez napredovanja motnje do hude jetrne poškodbe.
English: Cases of tuberculosis, sometimes fatal, including miliary tuberculosis and tuberculosis with extra-pulmonary location have been reported (see section 4.4).
Slovenian: Poročali so tudi o primerih tuberkuloze, včasih celo s smrtnim izidom, vključno z miliarno tuberkulozo in tuberkulozo izven pljuč (glejte poglavje 4.4).
English: SPIRIT evaluated the efficacy of infliximab induction therapy in 249 patients with plaque psoriasis that had previously received PUVA or systemic therapy.
Slovenian: V študiji SPIRIT so ocenjevali učinkovitost uvodne terapije z infliksimabom pri 249 bolnikih s psoriazo s plaki, ki so pred tem prejemali PUVA ali sistemsko terapijo.
English: • Reactions at the injection site such as pain, swelling, redness or itching
Slovenian: • reakcije na mestu injiciranja, na primer bolečina, otekanje, pordelost ali srbenje
English: In clinical studies, delayed hypersensitivity reactions have been uncommon and have occurred after Remicade-free intervals of less than 1 year (see sections 4.4 and 4.8).
Slovenian: V kliničnih študijah so bile pozne preobčutljivostne reakcije občasne in so se pojavile po premoru brez prejemanja zdravila manj kot 1 leto (glejte poglavji 4.4 in 4.8).
English: In ACT 1 and ACT 2, infliximab improved quality of life, confirmed by statistically significant improvement in both a disease specific measure, IBDQ, and by improvement in the generic 36-item short form survey SF-36.
Slovenian: V študijah ACT 1 in ACT 2 je infliksimab tudi izboljšal kakovost življenja bolnikov, kar je bilo potrjeno s statistično značilnim izboljšanjem rezultata vprašalnika za oceno vnetnih bolezni črevesja IBDQ, ki je specifičen za to bolezen, in z izboljšanjem rezultatov generične kratke ankete SF-36 s 36 postavkami.
English: • Merkel cell carcinoma (a type of skin cancer)
Slovenian: • karcinom Merklovih celic (vrsta kožnega raka)
English: In patients who have several or significant risk factors for tuberculosis and have a negative test for latent tuberculosis, antituberculosis therapy should be considered before the initiation of Remicade.
Slovenian: Pri bolnikih, ki imajo več dejavnikov tveganja oziroma pomembne dejavnike tveganja za tuberkulozo in pri katerih je bil test na latentno tuberkulozo negativen, premislite, ali bi bilo treba pri njih pred uvedbo zdravila Remicade najprej zdraviti tuberkulozo.
English: • Infection due to a live vaccine because of a weakened immune system.
Slovenian: • okužba zaradi živega cepiva zaradi oslabljenega imunskega sistema
English: If a patient develops symptoms suggestive of a lupus-like syndrome following treatment with Remicade and is positive for antibodies against double-stranded DNA, further treatment with Remicade must not be given (see section 4.8).
Slovenian: Če se po zdravljenju z zdravilom Remicade pri bolniku pojavijo simptomi, ki kažejo na lupusu podoben sindrom, in je bolnik pozitiven na protitelesa proti dvojnoverižni DNA, ne sme več prejeti tega zdravila (glejte poglavje 4.8).
English: At 102 weeks there were 80 subjects still on infliximab treatment and among those, 71 (89%) were ASAS 20 responders.
Slovenian: Čez 102 tedna se je z infliksimabom še vedno zdravilo 80 preiskovancev in od tega jih je imelo kar 71 (89 %) odziv ASAS 20.
English: • Some patients receiving Remicade have developed serious liver problems.
Slovenian: • Pri nekaterih bolnikih, ki prejemajo zdravilo Remicade, so se pojavile resne težave z jetri.
English: Long-term studies have not been performed to evaluate the carcinogenic potential of infliximab.
Slovenian: Dolgoročne študije za ovrednotenje kancerogenosti infliksimaba niso bile izvedene.
English: • Tell your doctor before you are given Remicade if you are a carrier of hepatitis B or have ever had it.
Slovenian: • Preden prejmete zdravilo Remicade, povejte zdravniku, če ste prenašalec hepatitisa B ali če ste ga imeli kdaj v preteklosti.
English: • Tell your doctor if you think you might be at risk of contracting hepatitis B.
Slovenian: • Povejte zdravniku, če mislite, da pri vas obstaja možnost, da bi se okužili s hepatitisom B.
English: Higher degrees of clinical response (ACR50 and ACR70) were observed in all infliximab groups at 30 and 54 weeks compared with methotrexate alone.
Slovenian: Izrazitejši klinični odziv (ACR 50 in ACR 70) so v 30. in 54. tednu opažali v vseh skupinah, ki so prejemale infliksimab, v primerjavi z bolniki, ki so prejemali le metotreksat.
English: Week 54 Clinical Response
Slovenian: 54. teden Klinični odziv